pyrroles has been researched along with Sarcoma, Clear Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casali, PG; Castelli, C; Colombo, C; Crippa, F; Morosi, C; Negri, T; Palassini, E; Pilotti, S; Rini, F; Rivoltini, L; Stacchiotti, S; Tazzari, M; Vergani, B; Villa, A | 1 |
| Casali, PG; Gronchi, A; Grosso, F; Morosi, C; Negri, T; Palassini, E; Pilotti, S; Stacchiotti, S | 1 |
2 other study(ies) available for pyrroles and Sarcoma, Clear Cell
| Article | Year |
|---|---|
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Agents; Female; Humans; Immunophenotyping; Indoles; Lymphocytes, Tumor-Infiltrating; MART-1 Antigen; Neoplasm Staging; Oncogene Proteins, Fusion; Positron-Emission Tomography; Pyrroles; Sarcoma, Clear Cell; Sunitinib; Tomography, X-Ray Computed; Transcription Factors; Treatment Outcome | 2015 |
Tumor response to sunitinib malate observed in clear-cell sarcoma.
Topics: Antineoplastic Agents; Female; Humans; Indoles; Middle Aged; Pyrroles; Sarcoma, Clear Cell; Soft Tissue Neoplasms; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2010 |